Clonal evolution and treatment outcomes in hematopoietic neoplasms arising in patients with germline RUNX1 mutations

Am J Hematol. 2020 Nov;95(11):E313-E315. doi: 10.1002/ajh.25965. Epub 2020 Sep 5.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Child
  • Child, Preschool
  • Clonal Evolution*
  • Core Binding Factor Alpha 2 Subunit / genetics*
  • Disease-Free Survival
  • Female
  • Germ-Line Mutation*
  • Hematologic Neoplasms* / genetics
  • Hematologic Neoplasms* / metabolism
  • Hematologic Neoplasms* / mortality
  • Hematologic Neoplasms* / therapy
  • Humans
  • Male
  • Middle Aged
  • Survival Rate

Substances

  • Core Binding Factor Alpha 2 Subunit
  • RUNX1 protein, human